Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,838.39 +1,476.84 (+2.26%) CMC Crypto 200
1,366.95 -6.89 (-0.50%)
FATE May 2024 7.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:46PM EDT. Market open.
| Previous close | 3.3000 |
| Open | 3.3000 |
| Bid | 2.0500 |
| Ask | 5.0000 |
| Strike | 7.50 |
| Expiry date | 2024-05-17 |
| Day's range | 3.3000 - 3.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
Insider MonkeyFate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript May 11, 2024 Fate Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Fate Therapeutics First Quarter 2024 Financial Results Conference Call [Operator Instructions]. This call is […]
Simply Wall St.Fate Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
Fate Therapeutics ( NASDAQ:FATE ) First Quarter 2024 Results Key Financial Results Net loss: US$48.0m (loss widened by...
- GuruFocus.com
Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial Performance Amid Clinical ...
Despite Revenue Growth, Losses Widen; Clinical Trials Progress in Autoimmune and Cancer Treatments
© 2024 Yahoo. All rights reserved.